paediatrics Brussels 17

Issues with Application of Metastatic Site RT within a global strategy

• Why? : Survival is driven by metastatic site failure and durability of systemic therapy is transient

Author

Rt modality Sites treated lf@rt

lf@nonRt

Gatcombe ebrt

Post induction

1/6

Bradfield ebrt

diag

1/17

4/4

Sibley

Tbi+ebrt

Post -SCT 1/10

Polishchuck ebrt

Post induction Post induction

3/19

128/506

Kandula

ebrt

3/13

Pmid :2523825;28068235;7607934;15022296;19211198